Lifetime Achievement
Awards
2026
Julio Chirinos
University of Pennsylvania
Perelman School of Medicine
Julio A. Chirinos, MD, PhD is a Professor of Medicine, Director of Investigator-Initiated Trials in Cardiovascular Medicine, Co-Director of the Clinical Research T32 Training Program in Cardiovascular Biology and Medicine, and Adjunct Faculty at the Center for Magnetic Resonance and Optical Imaging at the University of Pennsylvania Perelman School of Medicine. He is the current President of the North American Artery Society. He is also an adjunct Faculty member at the University of Ghent in Belgium.
He is a specialist in Internal Medicine and Cardiology, with a sub-specialty in cardiac imaging (echocardiography and cardiac magnetic resonance imaging). He directs an NIH-funded research program focused on the role of arterial stiffness and pulsatile hemodynamics in cardiovascular disease and mechanisms of human heart failure with preserved ejection fraction (HFpEF). Dr. Chirinos has published >250 papers in high-impact journals, including the New England Journal of Medicine, New England Journal of Medicine Evidence, The Lancet, The Lancet Respiratory Medicine, Journal of the American Medical Association (JAMA), Circulation, Hypertension and Journal of the American College of Cardiology (JACC).
He has received awards or honorary fellowships from the American Heart Association, the Inter-American Society of Cardiology, the American Society of Hypertension, the European Society of Cardiology and the Korean Society of Cardiology. He is an elected member of the American Society of Clinical Investigation (ASCI). He has served as associate Editor or Editorial Board member in multiple journals, including Circulation Heart Failure, Journal of Clinical Hypertension, Journal of the American College of Cardiology-Cardiovascular Imaging, American Journal of Hypertension, Pulse, Journal of Geriatric Cardiology, and Journal of the American Heart Association. He is the editor of the 2-volume textbook "Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease".
He has participated in various clinical expert committees for the American Heart Association, American Society of Echocardiography, European Society of Cardiology, American Society of Hypertension and European Association of Cardiovascular Imaging, and has been a speaker in >150 scientific sessions in national or international meetings.
2025
Gary F. Mitchell, M.D.
Framingham Heart Study Investigator
Gary F. Mitchell, MD is a cardiologist and internationally acknowledged leader in the field of vascular stiffness and pulsatile hemodynamics.
He received his undergraduate degree in chemistry from Vanderbilt University and his medical degree from Washington University in St. Louis. He completed his training in Medicine and Cardiology at Brigham and Women’s Hospital in Boston, where he served as a staff cardiologist until 1998.
In 1999, he became founder and president of Cardiovascular Engineering, Inc., which is an NIH-funded small business that designs and develops innovative devices that measure arterial stiffness. Dr. Mitchell has designed hardware and software and implemented concise yet comprehensive protocols that fully characterize pulsatile load and aortic function in small animals and in humans. He has organized large-scale, multicenter clinical trials and observational studies involving ~40,000 hemodynamic evaluations at 150 research institutions located throughout North America and in Iceland.
He joined the Framingham Heart Study as a Framingham Investigator in 1999 and became a collaborator on the AGES-Reykjavik and REFINE-Reykjavik Studies in 2006 and the Jackson Heart Study in 2010. Recent work has included detailed hemodynamic evaluations in participants in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the POINTER-NV study and the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
His research has focused on the role that aortic stiffening plays in the pathogenesis of cardiometabolic and cardiovascular disease. Dr. Mitchell’s work has elucidated the role of aortic stiffening and impedance matching in the downstream damage that occurs in microvascular beds throughout the body, especially in high-flow organs like the brain and kidneys.
Using devices designed and built by Cardiovascular Engineering, Dr. Mitchell has overseen detailed assessments of arterial stiffness and pulsatile hemodynamics in more than 20,000 research participants in various NIH-funded studies over the past 25 years. He has published over 250 peer-reviewed articles that have been cited more than 45,000 times and has an h-index of 96.
2024
Elaine M. Urbina
Cincinatti Children’s Hospital Medical Center
Dr. Elaine M. Urbina is a Professor of Pediatric Cardiology and the Director of Preventive Cardiology at Cincinnati Children’s Hospital Medical Center, where she also serves as Research Integrity Officer. She began her research career with the Bogalusa Heart Study (BHS) under the leadership of Dr. Gerald Berenson in 1991, where she supervised noninvasive cardiovascular (CV) imaging studies on younger adults for over a decade. In 2003, she moved to Cincinnati Children’s Hospital to begin research in cardiovascular assessment in adolescents with obesity related CV disease risk factors.
Dr. Urbina’s clinical activities focus on prevention (obesity, hypertension and dyslipidemias) while her research focuses on new non-invasive methods of assessing atherosclerotic CV target organ damage in youth related to CV risk factors especially those that cluster with obesity.
Dr. Urbina has provided cardiac and vascular training and core services to a variety of multicenter pediatric studies including CKiDs (chronic kidney disease), TODAY2 (type 2 diabetes), SEARCH 3 (type 1 diabetes), Udenefil & FUEL (single ventricle congenital heart disease), and DoIT (dyslipidemia). She also continues her work with BHS as a member of the International Childhood CV Cohorts Consortium (i3C) that follows seven major international cohorts that have been collecting CV risk factor data from pediatric patients. She recently completed her role as principal investigator in Strategically Focused Network in Hypertension (SFRN), an AHA-funded grant that explored population, clinical and epigenetic determinants of cardiac and vascular target organ damage in youth. Dr. Urbina has published well over 220 peerreviewed articles, book chapters and reviews. She has an h-index of 57 and her published work has been cited >24,400 times. Her research has been continuously funded by the National Institutes of Health and the American Heart Association (AHA) since 1994.
Dr. Urbina received her M.D. from the Medical College of Georgia, completed her residency in pediatrics at the University of California, San Francisco, and a fellowship in pediatric cardiology at Tulane University. She is a Fellow of the American Academy of Pediatrics (FAAP), the American College of Cardiology (FACC), and the American Heart Association (FAHA) and past chair of the Atherosclerosis, Hypertension and Obesity in Youth Committee of the CV Disease in the Young Council of AHA. She is also the Past-President of the North American Artery Society.
2023
Raymond Townsend
University of Pennsylvania
Raymond R. Townsend, MD, is a Professor of Medicine and an Associate Director of the Clinical and Translational Research Center at the University of Pennsylvania. He is currently a Co-Investigator on a 7-center U01 grant (DK-060984) studying factors in the progression of chronic kidney disease and the development and progression of cardiovascular disease in patients with CKD. His formal certifications are in internal medicine (ABIM), nephrology (ABIM), clinical pharmacology (ASCP) and hypertension (ASH). He is a Fellow in the American Heart Association and the Council for High Blood Pressure Research. Research interests include the role of vascular dynamics in CKD progression and the incidence/development of CVD in CKD, and the role of Renal Denervation in hypertension therapy. He was an empaneled member of JNC 8, is a current member of the Hypertension Canada Guidelines Committee and was the AHA Physician of the Year awardee for 2016.
2019
Wilmer Nichols, PhD
University of Florida
2019
Stanley Franklin, MD
University of California - Irvine